Dr Samantha South's Interview with KapitaList - Part 1LikeFollowShareDr Samantha South, Patrys' CEO, talks with KapitaList about the benefits of reformulating an existing drug compared to developing new formulations. This is Part 1, with Part 2 coming soon Your browser does not support the video tag.Share your feedbackQuestions (0)Post questionYour question will be sent privately to Patrys. The company may choose to make this question public.Start the conversationAsk Patrys a question about this update.Discover